Articles On Creso Pharma (ASX:CPH)

Globally, the cannabis market is estimated to be valued at around USD 150 billion. According to the European Consumer Staples Report released by Barclays in September 2018, the market value could shoot up, and may staggeringly increase to U...

Like Really? Boxing legend Mike Tyson is developing his own marijuana holiday resort, the Tyson Ranch near Desert Hot Spring. The resort will include a music festival venue, a luxury hotel, the world’s longest lazy river, Tyson University a...

The North Americans sure love their cannabis. It’s been less than a year since Canada became the first industrialised country in the world to legalise recreational cannabis and only the second overall behind Uruguay. Now 11 US states plus t...

The Althea Group Holdings Ltd (ASX: AGH) share price has started the week with a bang. In early afternoon trade the cannabis company’s shares are up a sizeable 16% to an all-time high of $1.10. Why is the Althea Group share price on a high...

Roots Sustainable Agricultural Technologies Ltd (ASX:ROO) has hosted a government, departmental and business delegation headed by the South Australia Minister for Primary Industries and Regional Development, The Hon Tim Whetstone MP, at its...

The Botanix Pharmaceuticals Ltd (ASX: BOT) share price has been a standout performer on the Australian share market on Thursday. In morning trade the clinical stage cannabinoid company’s shares rocketed 25% higher to an all-time high of 17....

Medlab Clinical Ltd Medlab Clinical Limited (ASX: MDC) is primarily engaged in sale of nutraceutical products (a mix of nutrition and pharmaceutical food product). It is also involved in pharmaceutical research and commercialisation. On 18...

Medical cannabis uses the marijuana plant or chemicals extracted from the plant for the treatment of diseases and symptoms, the plant (cannabis) possess over a hundred different chemicals called cannabinoids. There are a few forms of cannab...

The Cannabis sector is comparatively broad than the expectations of various market research houses, boutique research house or asset managers etc. The prevailing status of cannabis legalisation gradually appears positive, but the market wou...

Marijuana vs Liquor in the United States     Recent studies have revealed that the consumer demands in Cannabis and alcohol market space are not as correlated as was anticipated by the industry participants with the legalisation of marijuan...

As reported in last week’s 420 Report, emerging ASX cannabis group Creso Pharma Ltd (ASX:CPH) has received a takeover offer from Canadian cannabis company, PharmaCielo Ltd (TSXV:PCLO), for a total equity value of $122 million. Merger and ac...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

On Friday June 7, emerging cannabis group Creso Pharma Ltd (ASX:CPH) entered into a scheme implementation agreement with PharmaCielo Ltd (TSXV:PCLO), under which PharmaCielo would acquire Creso Pharma. The Schemes and the related arrangemen...

ShareCafeWho Is The Next Takeover Target? The takeover activity at the top end of town is permeating down to the small to mid-sized sector, raising the perennial question of who might be next to garner interest from cashed-up or merely oppo...

While several countries across the world are waking up to the benefits of medicalised/legalised marijuana, the industry has boomed rapidly and is one of the fastest growing markets in the world. Meanwhile, Australia’s cannabis market is als...

Sydney-based cannabis company Creso Pharma (ASX:CPH) has agreed to be acquired by Canadian company PharmaCielo for $122 million.

Creso Pharma Ltd (ASX:CPH) was front and centre in the ASX pot stock space this week, announcing on Friday that it had received a takeover offer from Canadian cannabis company PharmaCielo Limited (TSXV:PCLO). Creso Pharma, an early mover in...

07 Jun 2019 - Creso Pharma (ASX:CPH) is set to be acquired by PharmaCielo, a Toronto listed cannabis company.

Australian medicinal cannabis company Creso Pharma (ASX: CPH) has announced that it has entered an agreement to be acquired by a PharmaCielo for $122 million. PharmaCielo is a cannabis group listed on Canada's TSX Venture Exchange, with a...

Despite IG Markets forcing its users to sell the 19 global pot stocks on its books by 24 May, Australian pot stocks have generally been racking up the good news. IG were spooked by potential legal ramifications, mostly affecting UK investor...

This week, Canada has become the second country in the world — and the first industrialised nation — to legalise recreational cannabis use nationwide. ASX cannabis innovator, Creso Pharma (ASX:CPH), has welcomed this change with open arms.

Creso Pharma (ASX:CPH) is one step closer to launching its range of cannabis infused products.